Homepage
White Paper: Antibody-Targeted Precision Medicines
In our latest white paper, we examine the structural principles and technical hurdles that influence the success of antibody-targeted drugs
On-Demand Webinar: Target Deconvolution and Tractability Assessment
Learn how to apply target discovery and target deconvolution technologies in the early stages of drug development to enable faster, more accurate identification of viable targets
White Paper: Advanced Screening Strategies for Molecular Glue Discovery
In our latest white paper, we provide an in-depth perspective on strategies crucial for accelerating research focused on the development of molecular glues
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and beyond. Our world-class discovery platform is backed by nearly 3,000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules and oligonucleotides to peptides and antibodies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Latest White Paper
Screening Strategies for Molecular Glue Discovery
Screening Strategies for Molecular Glue Discovery
VIEW White PaperLatest Webinar
Webinar: Target Deconvolution and Tractability Assessment
Target Deconvolution and Tractability Assessment
VIEW WebinarLatest White Paper
Antibody-Targeted Precision Medicines
Antibody-Targeted Precision Medicines
VIEW White PaperLatest Article
mRNA Drugs: Progress, Production, and Prospects
mRNA Drugs: Progress, Production, and Prospects
VIEW ArticleEvolution of AAV Therapy: Challenges, Breakthroughs, and Future Directions
VIEW ArticleLatest Poster
Therapeutics for Alzheimer’s Using Antidiabetic Drugs
Therapeutics for Alzheimer’s Using Antidiabetic Drugs
VIEW PosterLatest Webinar
Solving the Complexities of T Cell Engager Development
Solving the Complexities of T Cell Engager Development
VIEW WebinarLatest Article
Radionuclide Drug Conjugates in Anticancer Treatment
Radionuclide Drug Conjugates in Anticancer Treatment
VIEW ArticleLatest Publication
Influence of ssDNA or dsDNA Tags on Ligand...
Influence of ssDNA or dsDNA Tags on Ligand Binding Affinity in DEL
VIEW PublicationHigh-throughput FAMA Assay to Measure Humoral Immunity against Varicella-Zoster Virus
VIEW Poster
